Medical Conditions and High-Altitude Travel

N Engl J Med. 2022 Jan 27;386(4):364-373. doi: 10.1056/NEJMra2104829.

Authors

Andrew M Luks¹, Peter H Hackett¹

Affiliation

¹ From the Division of Pulmonary, Critical Care, and Sleep Medicine, University of Washington, Seattle (A.M.L.); and the Altitude Research Center, Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora (P.H.H.).

PMID: 35081281
DOI: 10.1056/NEJMra2104829

No abstract available

Publication types

Review

MeSH terms

Acetazolamide / therapeutic use
Altitude
Altitude Sickness* / drug therapy
Altitude Sickness* / etiology
Altitude Sickness* / prevention & control
Altitude Sickness* / therapy
Brain Edema / etiology
Brain Edema / therapy
Chronic Disease / epidemiology
Dexamethasone / therapeutic use
Female
Humans
Hypertension, Pulmonary / therapy
Hypoxia / etiology*
Hypoxia / physiopathology
Male
Oxygen Saturation
Pregnancy
Risk Factors
Travel*

Substances

Dexamethasone
Acetazolamide

Supplementary concepts

Pulmonary edema of mountaineers